Pay in 4 interest-free payments of $6.24 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Sources Hims & Hers partnership deal with Novo Nordisk (March 9, 2026), Novo Nordisk Telehealth Hims Deal FDAs Concerns with Unapproved GLP-1 Drugs Used for Weight Loss, U.S
PeRx ships DSIP fully reconstituted from an FDA-registered 503A pharmacy
Research on IV glutathione in NAFLD reported measurable improvements in liver enzymes over treatment periods of several weeks
Retatrutide is an investigational GLP-1/GIP/glucagon triple receptor agonist with no MHRA or EMA marketing authorisation
This hormonal disbalance can lead to insulin sensitivity, type 2 diabetes, subfertility, & obesity
Things like knowing to proceed with caution for a patient with a history of pancreatitis, or remembering that the fine print for Zepbound recommends against its use in patients with severe gastroparesis
US$ 28.46
US$ 28.99
US$ 22.02
US$ 27.77
US$ 23.53
US$ 20.30
US$ 25.87
US$ 20.41
